US20160296945A1 - Systems and methods for active particle separation - Google Patents
Systems and methods for active particle separation Download PDFInfo
- Publication number
- US20160296945A1 US20160296945A1 US14/777,505 US201414777505A US2016296945A1 US 20160296945 A1 US20160296945 A1 US 20160296945A1 US 201414777505 A US201414777505 A US 201414777505A US 2016296945 A1 US2016296945 A1 US 2016296945A1
- Authority
- US
- United States
- Prior art keywords
- particles
- membrane
- reservoir
- magnetic
- magnetic field
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/32—Magnetic separation acting on the medium containing the substance being separated, e.g. magneto-gravimetric-, magnetohydrostatic-, or magnetohydrodynamic separation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/023—Separation using Lorentz force, i.e. deflection of electrically charged particles in a magnetic field
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/025—High gradient magnetic separators
- B03C1/031—Component parts; Auxiliary operations
- B03C1/033—Component parts; Auxiliary operations characterised by the magnetic circuit
- B03C1/0332—Component parts; Auxiliary operations characterised by the magnetic circuit using permanent magnets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/025—High gradient magnetic separators
- B03C1/031—Component parts; Auxiliary operations
- B03C1/033—Component parts; Auxiliary operations characterised by the magnetic circuit
- B03C1/0335—Component parts; Auxiliary operations characterised by the magnetic circuit using coils
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/23—Magnetic separation acting directly on the substance being separated with material carried by oscillating fields; with material carried by travelling fields, e.g. generated by stationary magnetic coils; Eddy-current separators, e.g. sliding ramp
- B03C1/24—Magnetic separation acting directly on the substance being separated with material carried by oscillating fields; with material carried by travelling fields, e.g. generated by stationary magnetic coils; Eddy-current separators, e.g. sliding ramp with material carried by travelling fields
- B03C1/253—Magnetic separation acting directly on the substance being separated with material carried by oscillating fields; with material carried by travelling fields, e.g. generated by stationary magnetic coils; Eddy-current separators, e.g. sliding ramp with material carried by travelling fields obtained by a linear motor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/28—Magnetic plugs and dipsticks
- B03C1/288—Magnetic plugs and dipsticks disposed at the outer circumference of a recipient
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/48—Treatment of water, waste water, or sewage with magnetic or electric fields
- C02F1/488—Treatment of water, waste water, or sewage with magnetic or electric fields for separation of magnetic materials, e.g. magnetic flocculation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/18—Magnetic separation whereby the particles are suspended in a liquid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/26—Details of magnetic or electrostatic separation for use in medical or biological applications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/0098—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation
Definitions
- the present disclosure relates to methods and systems for extracting particles from ferrofluids.
- WO2011/071912 and WO2012/057878 presents systems and methods for separating microparticles or cells contained in a ferrofluid medium using magnetic forces.
- the magnitude of these forces depend, in part, on the volume of the non-magnetic particles (e.g., moieties) for separation/targeting.
- a larger cell or microparticle displaces a larger ferrofluid volume, and experiences larger forces.
- Embodiments of this disclosure are a further application and development of previous series of disclosures, including, for example PCT publication no. WO2011/071912 and WO2012/057878, the noted disclosures of which are all herein incorporated by reference in their entireties.
- methods for extracting particles contained in a ferrofluid medium may comprise suspending particles of different sizes in a ferrofluid medium to form a mix and containing the mix in a reservoir (e.g., cylindrical), and applying a first magnetic field to at least a portion of the reservoir.
- the first magnetic field is configured to indirectly exert a force on at least a portion of the particles of at least one predetermined size and/or shape, and direct the portion of particles in a desired direction.
- Such method embodiments may additionally include one or more (or all, as applicable) of the following features (thereby establishing yet other embodiments):
- systems for extracting particles contained in a biocompatible ferrofluid medium may comprise a reservoir (e.g., cylindrical) configured to contain a ferrofluid medium containing particles of different sizes to form a mix, a first magnetic field source configured to indirectly exert a force on the particles to direct at least a portion of the particles of at least one size and/or shape in a desired direction, and an extraction opening arranged on a portion of the reservoir and/or in communication with the reservoir, the extraction opening configured to receive particles of at least one size and/or shape (may be predetermined size and/or shape) from the reservoir as a result of the exerted force.
- a reservoir e.g., cylindrical
- a first magnetic field source configured to indirectly exert a force on the particles to direct at least a portion of the particles of at least one size and/or shape in a desired direction
- an extraction opening arranged on a portion of the reservoir and/or in communication with the reservoir, the extraction opening configured to receive particles of at least one size and/or shape (may be predetermined size
- Such system embodiments may include one or more (or all, as applicable) of the following additional features (thereby establishing yet other embodiments):
- FIG. 1 is an illustration depicting structures of a reservoir and associated structures containing a ferrofluid and a mixture of microparticles, according to some embodiments.
- FIG. 2 is an illustration depicting structures of a reservoir and associated structures containing a ferrofluid and a mixture of microparticles, including a magnetic source for applying a magnetic field to the reservoir, according to some embodiments.
- FIG. 3 is an illustration depicting structures of a reservoir and associated structures containing a ferrofluid and a mixture of microparticles, including two magnetic sources for applying one or more magnetic fields to the reservoir, according to some embodiments.
- FIG. 4 is an illustration depicting structures of a membrane with pore sizes larger than the individual particles/cells placed within a reservoir containing a ferrofluid medium.
- FIG. 5 is an illustration depicting the cross-sectional and schematic view of a membrane with pores within a ferrofluid medium.
- a reservoir 10 containing a ferrofluid 11 (which in some embodiments is biocompatible) and a mixture of microparticles/cells 12 having different sizes (in some embodiments).
- a ferrofluid 11 which in some embodiments is biocompatible
- a mixture of microparticles/cells 12 having different sizes in some embodiments.
- FIG. 2 illustrates some embodiments, where a reservoir 20 containing a ferrofluid 21 with a mixture of microparticles 22 of different sizes, and includes at least one magnetic source 25 for applying a magnetic field to the ferrofluid 21 , which may be arranged either internal or external to the reservoir 20 .
- the particles 22 include biological cells and moieties.
- the magnetic field may be configured to exert one or more forces on the ferrofluid 21 and may be generated via, for example, one or more: external magnets, current-carrying electrodes, solenoid, and electromagnets. In one embodiment, the magnetic field may surround at least a portion of the reservoir 20 .
- the reservoir 10 includes or is in communication with an extraction opening 23 .
- the force(s) exerted by the magnetic fields on the ferrofluid 21 cause the particles 22 , in some embodiments, to be directed in a desired direction. Such a desired direction may be toward the extraction opening 23 , away from the extraction opening 23 , toward a central axis of the reservoir 20 , and away from a central axis of the reservoir 20 , according to some embodiments.
- the particles 22 include, in one embodiment, smaller particles relative to the remainder of the particles 22 in the ferrofluid 21 and larger particles relative the remainder of the particles 22 in the ferrofluid 21 .
- the larger particles feel much larger repulsive forces, and can hence be dynamically levitated above the outlet, whereas the smaller particles will be dragged out with flow.
- a flow outlet 24 is provided on and/or in communication with the reservoir.
- the exerted force may be configured to carry away a portion of particles 22 in a flow out of the reservoir 20 via the flow outlet 24 .
- Such a flow out of the reservoir 20 may be generated via an external force, for example, a pressure source or a pump.
- the pushing force in conjunction with the flow rate out of the reservoir/vial into the extraction hole, could be engineered such that moieties larger than a selectable threshold volume could be continuously and dynamically repelled away the vial's outlet under steady state conditions. In this fashion, moieties larger than the selectable threshold volume could be excluded from the fluidic network downstream.
- the active pre-filter described here avoids the shortcomings of mechanical filters by achieving size-based separation and exclusion within the 3D volume of the vial/reservoir, instead of the 2D surface of a mechanic filter ( FIGS. 1 and 2 ). Those microparticles or cells that are larger than the selectable threshold are continuously suspended and mixed in the biocompatible ferrofluid, hence preventing large scales of clustering and possible clogging issues.
- FIG. 3 illustrate some embodiments, where a reservoir 30 containing a ferrofluid 31 and a mixture of microparticles 32 with different sizes.
- a second magnetic field source 36 maybe place opposite the extraction opening 33 to accelerate the transport of microparticles 32 towards it. In this fashion, the effect of any other forces (such as buoyancy) on the delivery efficiency of target particles/cells 32 to the fluidic network downstream may be minimized.
- the larger particles would also cluster and levitate closer to the outlet, the relative intensity of the two field sources may be tuned to prevent any cluster from clogging the outlet.
- clusters may be broken by periodic intensity modulations in at least one field sources.
- a vial/reservoir with cylindrical symmetry sits on top of a tunable source of magnetic fields, preferably encompassing similar symmetry in its geometry.
- the magnetic field and its gradient are designed to push the target moieties suspended in a biocompatible ferrofluid up and towards the center of the vial, into the region of strongest flow (away from the vial's interior surfaces).
- the biocompatible ferrofluid is pulled into an extraction hole at the center bottom of the vial via externally imposed flow conditions (e.g., a pump or pressure device).
- the intensity of the magnetic field and its gradient are engineered so as to push moieties larger than a selectable size up and away from the vial's outlet at the bottom faster than the maximum flow rate near the vicinity of the outlet.
- a recirculation region within toroidal symmetry is formed around the outlet, capturing and circulating the filtered moieties.
- the filtered moieties hover dynamically a certain distance over the outlet. In such cases, as the filtration progresses, the filtered moieties are intentionally allowed to cluster and pushed further up.
- FIG. 4 illustrates some embodiments, where a reservoir 40 containing a ferrofluid 41 and a mixture of microparticles 42 with different sizes.
- a first magnetic field source 45 placed proximate to the extraction opening 43 and a second magnetic field source 46 placed opposite of the first magnetic field source 45 to accelerate the transport of microparticles 42 toward the extraction opening 43 .
- a non-magnetic membrane 47 configured with pore sizes larger than microparticles 42 within the reservoir 40 containing the ferrofluid mix 41 of ferrofluid and target particles.
- Such membranes function to capture target particles using magnetic fields. For example, in the absence of externally applied magnetic fields, micro/target particles/cells may flow through the membrane's pores.
- the non-magnetic membrane 47 may be configured to direct debris, particulate contaminants and microparticles/cells 42 , larger than a size threshold value (for example), away from the pores of the membrane and into the space between the pores. Particles 42 smaller than the threshold, in some embodiments, tend to follow flow streamlines and pass through the non-magnetic membrane 47 .
- the non-magnetic membrane in one embodiment, is made out of a plastic sheet.
- the pores may be configured as any size (on a scale relative to the teachings herein, e.g., pore sizes of 1-200 ⁇ m, 5-50 ⁇ m, 10-100 ⁇ m, 20-30 ⁇ m), and any shape, including, for example, round, circular, polygonal, rectangular/slit, square, and/or elliptical.
- the shape of the pores is configured to aid in the intended functionality of capturing particles using magnetic forces and not by pore size (i.e., pore size relative to target particle size), such that the overall pore size, in some embodiments, is larger than the target particle size.
- a plurality of pores may be arranged in predetermined patterns (i.e., not random), and may be configured in such a manner to aid in the capture functionality of the membrane feature.
- groups of pores on the same or different size, shape, etc. may be arranged in repeated groups or matrix.
- Such pores may be manufactured into a sheet of material, by, for example, laser etching.
- FIG. 5 illustrates some embodiments, magnetic field lines prefer to stay within the magnetic medium of the ferrofluid.
- the porous membrane 50 is made out of a non-magnetic material (such as a thin sheet of plastic), field lines traversing its thickness get concentrated within the pores. This effect results in stronger field amplitudes within the pores, compared to just outside them—thereby creating a magnetic field gradient that pushes particles up and away from the pores. Since the magnetic force on particles is proportional to the volume of ferrofluid that they displace, larger particles 51 tend to accumulate over the membrane 50 in the space between the spores, while small particles 52 follow flow streamlines and pass through the membrane 50 .
- the porous membrane may be made from a thin foil of a magnetic material configured with a magnetic susceptibility which is greater than that of the ferrofluid at the magnetic excitation frequencies used (for example).
- a magnetic field e.g., external magnetic field
- the magnetic field lines traversing the thickness of the magnetic membrane tend to remain within the membrane material. This effect, according to some embodiments, may result in weaker field amplitudes within the pores compared to just outside them, which thereby creates a magnetic field gradient that can push the non-magnetic particles towards the pores.
- magnetic beads if magnetic beads are added to the sample mixture, they may be attracted towards the surface of the magnetic membrane between the pores. In this same fashion, functionalized magnetic beads may be used to rapidly pull down, isolate and purify target moieties in biocompatible ferrofluids.
- the porous membrane is not absolutely necessary for the active filter to function, but by creating strong and localized field gradients, it allows for a much more robust and easily tunable size-based separation.
- the retained particles/cells can be selectively released back into the flow stream.
- red blood cells and white blood cells may be sequentially retained and selectively entered into the assay channels by reducing the magnetic field amplitude appropriately for each cell size.
- labor- and time-intensive cell separation techniques such as centrifugation
- the field magnitudes may be sequentially controlled and timed by a microprocessor as part of an automated assay.
- multiple membranes may be stacked serially along the fluidic pathway, and may be exposed to the same magnetic field sources (for example).
- Each membrane may be positioned parallel to others in the stack and, in some embodiments, at least partially orthogonal to the flow direction.
- a minimum spacing between each membrane is chosen to correspond to at least their thickness, so that field line density has space to return to normal between each membrane (i.e., in some embodiments, this is provided to avoid one membrane from interfering with the filtering ability of its neighbor).
- a complex mixture with various cell/particle sizes (such as whole blood) may be fractionated very rapidly based on size.
- the porous membrane may be used to rapidly immobilize and hold down functionalized beads over its surface. These beads would carry at least one kind of receptor molecule, antibody, DNA fragment and other ligand on their outer surface. As the beads are held on the membrane with magnetic fields, a mixture of target and non-target moieties may be flown through the active filter and rapidly captured on the “carpet” of beads sitting over the porous membrane.
- the target moieties may be small molecules, proteins, complementary DNA fragments, viruses, bacteria or even larger cells. Once the target moieties have been captured on the beads and isolated from the initial mixture, they could be either tagged and quantified directly on the porous membrane, or be released into the assay chamber for further processing and quantification. With this approach, what is normally a lengthy and labor-intensive sample preparation, incubation and isolation process can be reduced to an automatic and rapid step within a simple instrument.
- actual bacteria and cells are held on the porous membrane surface with magnetic fields, and can be exposed to molecular tags, candidate drug molecules, antibodies or other proteins, with the express purpose of dramatically accelerating the incubation processes associated with binding ligands to cellular surface biomarkers.
- the porous membrane may also be functionalized with ligands that capture the pathogens or cells held on its surface. This approach is especially useful if it is desired to have target pathogens or cells remain on the membrane surface while other moieties present in the initial sample mixture are washed away when the magnetic fields are turned down (such as in sample purification or immune-sorbent assays).
- the active filter not only solves the mass transport limitations associated with incubation steps in molecular or cellular assays, it also avoids the labor-intensive washing steps that typically follow binding/capture reactions.
- embodiments of the devices, systems and methods have been described herein. As noted elsewhere, these embodiments have been described for illustrative purposes only and are not limiting. Other embodiments are possible and are covered by the disclosure, which will be apparent from the teachings contained herein. Thus, the breadth and scope of the disclosure should not be limited by any of the above-described embodiments but should be defined only in accordance with claims supported by the present disclosure and their equivalents.
- embodiments of the subject disclosure may include methods, systems and devices which may further include any and all elements from any other disclosed methods, systems, and devices, including any and all elements corresponding to target particle separation, focusing/concentration. In other words, elements from one or another disclosed embodiments may be interchangeable with elements from other disclosed embodiments.
- one or more features/elements of disclosed embodiments may be removed and still result in patentable subject matter (and thus, resulting in yet more embodiments of the subject disclosure).
- some embodiments of the present disclosure may be patentably distinct from one and/or another reference by specifically lacking one or more elements/features.
- claims to certain embodiments may contain negative limitation to specifically exclude one or more elements/features resulting in embodiments which are patentably distinct from the prior art which include such features/elements.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Water Supply & Treatment (AREA)
- Environmental & Geological Engineering (AREA)
- Hydrology & Water Resources (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Fluid Mechanics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Separation Of Solids By Using Liquids Or Pneumatic Power (AREA)
Abstract
Description
- This application claims benefit under 35 USC 119(e) of U.S. provisional patent application Nos. 61/794,885, filed Mar. 15, 2013, and entitled, “PCB-Based Magnetic Excitation Approach” the entire disclosure of which is herein incorporated by reference in its entirety.
- The present disclosure relates to methods and systems for extracting particles from ferrofluids.
- WO2011/071912 and WO2012/057878 presents systems and methods for separating microparticles or cells contained in a ferrofluid medium using magnetic forces. The magnitude of these forces depend, in part, on the volume of the non-magnetic particles (e.g., moieties) for separation/targeting. Moreover, a larger cell or microparticle displaces a larger ferrofluid volume, and experiences larger forces.
- Mechanical exclusion, via well-known filtration is, by its very nature, prone to clogging, and also subsequent increases in pressure drop across the filter as the filter becomes more and more clogged. Such filtration means rely on physically stopping a large enough target particle across a smaller opening on a surface.
- Embodiments of this disclosure are a further application and development of previous series of disclosures, including, for example PCT publication no. WO2011/071912 and WO2012/057878, the noted disclosures of which are all herein incorporated by reference in their entireties.
- In some embodiments, methods for extracting particles contained in a ferrofluid medium are provided. Such methods may comprise suspending particles of different sizes in a ferrofluid medium to form a mix and containing the mix in a reservoir (e.g., cylindrical), and applying a first magnetic field to at least a portion of the reservoir. The first magnetic field is configured to indirectly exert a force on at least a portion of the particles of at least one predetermined size and/or shape, and direct the portion of particles in a desired direction.
- Such method embodiments may additionally include one or more (or all, as applicable) of the following features (thereby establishing yet other embodiments):
-
- applying includes surrounding at least the portion of the reservoir with the magnetic field;
- the particles comprise at least one of biological cells and moieties;
- the reservoir includes or is in communication with an extraction opening;
- the desired direction is toward the extraction opening;
- the desired direction is away from the extraction opening;
- the desired direction is toward a central axis the reservoir;
- the desired direction is away from a central axis of the reservoir;
- the predetermined size comprises smaller particles relative to the remainder of the particles in the ferrofluid medium;
- the predetermined size comprises larger particles relative to the remainder of the particles in the ferrofluid medium;
- a flow outlet is provided on and/or in communication with the reservoir;
- the exerted force is configured such that the portion of particles are carried away in a flow out of the reservoir via the flow outlet;
- applying an external force on the reservoir to establish the flow out the flow outlet, where;
- the external force is applied via a pressure source, where the pressure source is a pump;
- accelerating a flow of the portion of particles via a second magnetic field, the second magnetic field generated by a second magnetic field source arranged on a portion of the reservoir positioned opposite to the extraction opening;
- a non-magnetic membrane configured with pore sizes larger than particles within the reservoir to direct particles in a second desired direction;
- the second desired direction is toward spaces between the pores of the membrane, wherein the membrane spaces are configured to retain the particles;
- the second desired direction is toward the pores of the membrane, such that the particles pass through the membrane;
- the non-magnetic membrane comprises a plastic sheet;
- the first magnetic field source is configured to reduce the amplitude or substantially eliminate the first magnetic field or the effects thereof;
- the amplitude is selected based on the size of the size of the portion of the particles;
- a plurality of non-magnetic beads suspended in the ferrofluid, the non-magnetic beads being functionalized with at least one predetermined receptor configured to bind with a target particle;
- wherein the at least one predetermined receptor include at least one of a molecule, a cell, an antibody, DNA or fragment thereof, and a ligand;
- the magnetic field is configured to direct the target particles toward the space between the pores of the membrane which are configured to retain the target particles; and
- detecting means to at least one of track or count the retained target particles.
- In some embodiment of the disclosure, systems for extracting particles contained in a biocompatible ferrofluid medium are provided. Such systems may comprise a reservoir (e.g., cylindrical) configured to contain a ferrofluid medium containing particles of different sizes to form a mix, a first magnetic field source configured to indirectly exert a force on the particles to direct at least a portion of the particles of at least one size and/or shape in a desired direction, and an extraction opening arranged on a portion of the reservoir and/or in communication with the reservoir, the extraction opening configured to receive particles of at least one size and/or shape (may be predetermined size and/or shape) from the reservoir as a result of the exerted force.
- Such system embodiments, may include one or more (or all, as applicable) of the following additional features (thereby establishing yet other embodiments):
-
- the first magnetic field source is configured to generate a first magnetic field surrounding at least the portion of the reservoir;
- the particles comprise at least one of biological cells and moieties;
- the desired direction is toward the extraction opening;
- the desired direction is away from the extraction opening;
- the desired direction is toward a central axis of the reservoir;
- the desired direction is away from a central axis of the reservoir;
- the predetermined size comprises smaller particles relative to the remainder of the particles in the ferrofluid medium;
- the predetermined size comprises larger particles relative to the remainder of the particles in the ferrofluid medium;
- a flow outlet provided on and/or in communication with the reservoir;
- the exerted force is configured such that the portion of particles are carried away in a flow out of the reservoir via the flow outlet, and wherein the desired direction is away from the extraction opening;
- applying a non-magnetic external force on the reservoir to establish the flow out the flow outlet;
- the external force is applied via a pressure source, where the pressure source is a pump; and
- a second magnetic field source arranged on a portion of the reservoir located opposite to the extraction opening, the second magnetic field source configured to generate a second magnetic field on the portion of the particles to accelerate a flow of the portion of particles to the extraction opening;
- a non-magnetic membrane configured with pore sizes larger than particles within the reservoir to direct particles in a second desired direction;
- the second desired direction is toward spaces between the pores of the membrane, wherein the membrane spaces are configured to retain the particles;
- the second desired direction is toward the pores of the membrane, such that the particles pass through the membrane;
- the non-magnetic membrane comprises a plastic sheet;
- the first magnetic field source is configured to reduce the amplitude or substantially eliminate the first magnetic field or the effects thereof;
- the amplitude is selected based on the size of the size of the portion of the particles;
- a plurality of non-magnetic beads suspended in the ferrofluid, the non-magnetic beads being functionalized with at least one predetermined receptor configured to bind with a target particle;
- the at least one predetermined receptor include at least one of a molecule, a cell, an antibody, DNA or fragment thereof, and a ligand;
- the magnetic field is configured to direct the target particles toward the space between the pores of the membrane which are configured to retain the target particles; and
- detecting mean to at least one of track or count the retained target particles (such detecting means being well known in the art).
- The above-noted embodiments, as well as other embodiments, will become even more evident with reference to the following detailed description and associated drawing, a brief description of which is provided below.
-
FIG. 1 is an illustration depicting structures of a reservoir and associated structures containing a ferrofluid and a mixture of microparticles, according to some embodiments. -
FIG. 2 is an illustration depicting structures of a reservoir and associated structures containing a ferrofluid and a mixture of microparticles, including a magnetic source for applying a magnetic field to the reservoir, according to some embodiments. -
FIG. 3 is an illustration depicting structures of a reservoir and associated structures containing a ferrofluid and a mixture of microparticles, including two magnetic sources for applying one or more magnetic fields to the reservoir, according to some embodiments. -
FIG. 4 is an illustration depicting structures of a membrane with pore sizes larger than the individual particles/cells placed within a reservoir containing a ferrofluid medium. -
FIG. 5 is an illustration depicting the cross-sectional and schematic view of a membrane with pores within a ferrofluid medium. - As shown in
FIG. 1 , areservoir 10 containing a ferrofluid 11 (which in some embodiments is biocompatible) and a mixture of microparticles/cells 12 having different sizes (in some embodiments). InFIG. 1 , no external forces are applied to the fluid, reservoir and/or particles, and ignoring buoyancy issues, a random mixture of particles may flow through anextraction opening 13 of the reservoir. -
FIG. 2 illustrates some embodiments, where areservoir 20 containing aferrofluid 21 with a mixture ofmicroparticles 22 of different sizes, and includes at least onemagnetic source 25 for applying a magnetic field to theferrofluid 21, which may be arranged either internal or external to thereservoir 20. Theparticles 22 include biological cells and moieties. The magnetic field may be configured to exert one or more forces on theferrofluid 21 and may be generated via, for example, one or more: external magnets, current-carrying electrodes, solenoid, and electromagnets. In one embodiment, the magnetic field may surround at least a portion of thereservoir 20. Thereservoir 10 includes or is in communication with anextraction opening 23. The force(s) exerted by the magnetic fields on theferrofluid 21 cause theparticles 22, in some embodiments, to be directed in a desired direction. Such a desired direction may be toward theextraction opening 23, away from theextraction opening 23, toward a central axis of thereservoir 20, and away from a central axis of thereservoir 20, according to some embodiments. Theparticles 22 include, in one embodiment, smaller particles relative to the remainder of theparticles 22 in theferrofluid 21 and larger particles relative the remainder of theparticles 22 in theferrofluid 21. The larger particles feel much larger repulsive forces, and can hence be dynamically levitated above the outlet, whereas the smaller particles will be dragged out with flow. In one embodiment, aflow outlet 24 is provided on and/or in communication with the reservoir. The exerted force may be configured to carry away a portion ofparticles 22 in a flow out of thereservoir 20 via theflow outlet 24. Such a flow out of thereservoir 20 may be generated via an external force, for example, a pressure source or a pump. - It is possible to create a magnetic field pattern around a sample reservoir or vial carrying microparticles or cells suspended within a biocompatible ferrofluid in order to push those moieties either toward or away from an extraction hole. This approach and the device that achieves this manipulation could be used in the context of either speeding or delaying the delivery of the target moieties from the volume of the reservoir into the fluidic cartridge downstream. The magnitude of this magnetic force would depend in part on the intensity of the magnetic field sources, as well as their relative geometry with respect to that of the reservoir. The magnetic force also depends on the ferrofluid susceptibility and the volume of the microparticles/cells. Hence, the pushing force, in conjunction with the flow rate out of the reservoir/vial into the extraction hole, could be engineered such that moieties larger than a selectable threshold volume could be continuously and dynamically repelled away the vial's outlet under steady state conditions. In this fashion, moieties larger than the selectable threshold volume could be excluded from the fluidic network downstream.
- What is described here is an “active pre-filter” that works on dynamic magnetic exclusion principles in steady-state flow and magnetic excitation conditions. Most other size-based filtration methods rely on mechanical obstacles (such as pore sizes of a given diameter in filter paper or micro fabricated devices) and work on static mechanical exclusion principles.
- The active pre-filter described here avoids the shortcomings of mechanical filters by achieving size-based separation and exclusion within the 3D volume of the vial/reservoir, instead of the 2D surface of a mechanic filter (
FIGS. 1 and 2 ). Those microparticles or cells that are larger than the selectable threshold are continuously suspended and mixed in the biocompatible ferrofluid, hence preventing large scales of clustering and possible clogging issues. - Even if the filtered moieties tend to cluster within the ferrofluid, their increased overall hydrodynamic diameter will result in substantially larger repulsion forces on them. With flow drag roughly proportional to the hydrodynamic diameter (˜d) and magnetic forces proportional to the hydrodynamic volume (˜d3), the larger cluster will be pushed further away from the outlet. Hence, this active pre-filter features a negative feedback mechanism that naturally prevents potential clogging issues (
FIG. 2 ). -
FIG. 3 illustrate some embodiments, where areservoir 30 containing aferrofluid 31 and a mixture ofmicroparticles 32 with different sizes. A secondmagnetic field source 36 maybe place opposite theextraction opening 33 to accelerate the transport ofmicroparticles 32 towards it. In this fashion, the effect of any other forces (such as buoyancy) on the delivery efficiency of target particles/cells 32 to the fluidic network downstream may be minimized. The larger particles would also cluster and levitate closer to the outlet, the relative intensity of the two field sources may be tuned to prevent any cluster from clogging the outlet. Moreover, clusters may be broken by periodic intensity modulations in at least one field sources. - It may be necessary to intentionally and periodically stir up the contents of the vial so as to break up clusters of large microparticles or cells. This will ensure that anything smaller than the selection threshold is not impeded by or somehow stuck within the clusters. This effect might be easily achieved by modulating the intensity of the externally applied magnetic field and allowing the flow to break the dynamic clusters apart (
FIG. 3 ). - In the simplest realization of the active pre-filter, a vial/reservoir with cylindrical symmetry sits on top of a tunable source of magnetic fields, preferably encompassing similar symmetry in its geometry. The magnetic field and its gradient are designed to push the target moieties suspended in a biocompatible ferrofluid up and towards the center of the vial, into the region of strongest flow (away from the vial's interior surfaces). The biocompatible ferrofluid is pulled into an extraction hole at the center bottom of the vial via externally imposed flow conditions (e.g., a pump or pressure device). The intensity of the magnetic field and its gradient are engineered so as to push moieties larger than a selectable size up and away from the vial's outlet at the bottom faster than the maximum flow rate near the vicinity of the outlet. In certain instances, a recirculation region within toroidal symmetry is formed around the outlet, capturing and circulating the filtered moieties. In other geometries, the filtered moieties hover dynamically a certain distance over the outlet. In such cases, as the filtration progresses, the filtered moieties are intentionally allowed to cluster and pushed further up.
-
FIG. 4 illustrates some embodiments, where areservoir 40 containing aferrofluid 41 and a mixture ofmicroparticles 42 with different sizes. A firstmagnetic field source 45 placed proximate to theextraction opening 43 and a second magnetic field source 46 placed opposite of the firstmagnetic field source 45 to accelerate the transport ofmicroparticles 42 toward theextraction opening 43. - In some embodiments, a
non-magnetic membrane 47 configured with pore sizes larger thanmicroparticles 42 within thereservoir 40 containing theferrofluid mix 41 of ferrofluid and target particles is provided. Such membranes function to capture target particles using magnetic fields. For example, in the absence of externally applied magnetic fields, micro/target particles/cells may flow through the membrane's pores. However, upon applying a magnetic fields, thenon-magnetic membrane 47 may be configured to direct debris, particulate contaminants and microparticles/cells 42, larger than a size threshold value (for example), away from the pores of the membrane and into the space between the pores.Particles 42 smaller than the threshold, in some embodiments, tend to follow flow streamlines and pass through thenon-magnetic membrane 47. - The non-magnetic membrane, in one embodiment, is made out of a plastic sheet. In addition, in some embodiments, the pores may be configured as any size (on a scale relative to the teachings herein, e.g., pore sizes of 1-200 μm, 5-50 μm, 10-100 μm, 20-30 μm), and any shape, including, for example, round, circular, polygonal, rectangular/slit, square, and/or elliptical. In some embodiments, the shape of the pores is configured to aid in the intended functionality of capturing particles using magnetic forces and not by pore size (i.e., pore size relative to target particle size), such that the overall pore size, in some embodiments, is larger than the target particle size.
- A plurality of pores, according to some embodiments, may be arranged in predetermined patterns (i.e., not random), and may be configured in such a manner to aid in the capture functionality of the membrane feature. Thus, groups of pores on the same or different size, shape, etc., may be arranged in repeated groups or matrix. Such pores may be manufactured into a sheet of material, by, for example, laser etching.
-
FIG. 5 illustrates some embodiments, magnetic field lines prefer to stay within the magnetic medium of the ferrofluid. If theporous membrane 50 is made out of a non-magnetic material (such as a thin sheet of plastic), field lines traversing its thickness get concentrated within the pores. This effect results in stronger field amplitudes within the pores, compared to just outside them—thereby creating a magnetic field gradient that pushes particles up and away from the pores. Since the magnetic force on particles is proportional to the volume of ferrofluid that they displace,larger particles 51 tend to accumulate over themembrane 50 in the space between the spores, whilesmall particles 52 follow flow streamlines and pass through themembrane 50. - In some embodiments, the porous membrane may be made from a thin foil of a magnetic material configured with a magnetic susceptibility which is greater than that of the ferrofluid at the magnetic excitation frequencies used (for example). For instance, such magnetic membranes may be machined out of a thin foil of nickel via, for example, lithographic etching or laser machining Accordingly, upon the application of a magnetic field (e.g., external magnetic field), the magnetic field lines traversing the thickness of the magnetic membrane tend to remain within the membrane material. This effect, according to some embodiments, may result in weaker field amplitudes within the pores compared to just outside them, which thereby creates a magnetic field gradient that can push the non-magnetic particles towards the pores. In some embodiments, if magnetic beads are added to the sample mixture, they may be attracted towards the surface of the magnetic membrane between the pores. In this same fashion, functionalized magnetic beads may be used to rapidly pull down, isolate and purify target moieties in biocompatible ferrofluids.
- The porous membrane is not absolutely necessary for the active filter to function, but by creating strong and localized field gradients, it allows for a much more robust and easily tunable size-based separation.
- When the fields are lowered in magnitude or turned off completely, the retained particles/cells can be selectively released back into the flow stream. For instance, in an assay that is conducted with a mixture of whole blood and blood-compatible ferrofluid, platelets, red blood cells and white blood cells may be sequentially retained and selectively entered into the assay channels by reducing the magnetic field amplitude appropriately for each cell size. Hence, with the use of the active pre-filter, labor- and time-intensive cell separation techniques (such as centrifugation) may be rendered redundant, resulting in much quicker and simpler assay protocols. The field magnitudes may be sequentially controlled and timed by a microprocessor as part of an automated assay.
- In yet another embodiment, multiple membranes may be stacked serially along the fluidic pathway, and may be exposed to the same magnetic field sources (for example). Each membrane may be positioned parallel to others in the stack and, in some embodiments, at least partially orthogonal to the flow direction. In some embodiments, a minimum spacing between each membrane is chosen to correspond to at least their thickness, so that field line density has space to return to normal between each membrane (i.e., in some embodiments, this is provided to avoid one membrane from interfering with the filtering ability of its neighbor). In some embodiments, using stacked, non-magnetic membranes with progressively smaller pore sizes, a complex mixture with various cell/particle sizes (such as whole blood) may be fractionated very rapidly based on size.
- In some embodiments, the porous membrane may be used to rapidly immobilize and hold down functionalized beads over its surface. These beads would carry at least one kind of receptor molecule, antibody, DNA fragment and other ligand on their outer surface. As the beads are held on the membrane with magnetic fields, a mixture of target and non-target moieties may be flown through the active filter and rapidly captured on the “carpet” of beads sitting over the porous membrane. The target moieties may be small molecules, proteins, complementary DNA fragments, viruses, bacteria or even larger cells. Once the target moieties have been captured on the beads and isolated from the initial mixture, they could be either tagged and quantified directly on the porous membrane, or be released into the assay chamber for further processing and quantification. With this approach, what is normally a lengthy and labor-intensive sample preparation, incubation and isolation process can be reduced to an automatic and rapid step within a simple instrument.
- In some embodiments, actual bacteria and cells are held on the porous membrane surface with magnetic fields, and can be exposed to molecular tags, candidate drug molecules, antibodies or other proteins, with the express purpose of dramatically accelerating the incubation processes associated with binding ligands to cellular surface biomarkers.
- The porous membrane may also be functionalized with ligands that capture the pathogens or cells held on its surface. This approach is especially useful if it is desired to have target pathogens or cells remain on the membrane surface while other moieties present in the initial sample mixture are washed away when the magnetic fields are turned down (such as in sample purification or immune-sorbent assays). As such, the active filter not only solves the mass transport limitations associated with incubation steps in molecular or cellular assays, it also avoids the labor-intensive washing steps that typically follow binding/capture reactions.
- Any and all references to publications or other documents, including but not limited to, patents, patent applications, articles, webpages, books, etc., presented in the present application, are herein incorporated by reference in their entirety.
- Example embodiments of the devices, systems and methods have been described herein. As noted elsewhere, these embodiments have been described for illustrative purposes only and are not limiting. Other embodiments are possible and are covered by the disclosure, which will be apparent from the teachings contained herein. Thus, the breadth and scope of the disclosure should not be limited by any of the above-described embodiments but should be defined only in accordance with claims supported by the present disclosure and their equivalents. Moreover, embodiments of the subject disclosure may include methods, systems and devices which may further include any and all elements from any other disclosed methods, systems, and devices, including any and all elements corresponding to target particle separation, focusing/concentration. In other words, elements from one or another disclosed embodiments may be interchangeable with elements from other disclosed embodiments. In addition, one or more features/elements of disclosed embodiments may be removed and still result in patentable subject matter (and thus, resulting in yet more embodiments of the subject disclosure). Correspondingly, some embodiments of the present disclosure may be patentably distinct from one and/or another reference by specifically lacking one or more elements/features. In other words, claims to certain embodiments may contain negative limitation to specifically exclude one or more elements/features resulting in embodiments which are patentably distinct from the prior art which include such features/elements.
Claims (34)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/777,505 US20160296945A1 (en) | 2013-03-15 | 2014-03-14 | Systems and methods for active particle separation |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361794885P | 2013-03-15 | 2013-03-15 | |
US14/777,505 US20160296945A1 (en) | 2013-03-15 | 2014-03-14 | Systems and methods for active particle separation |
PCT/US2014/029336 WO2014144782A2 (en) | 2013-03-15 | 2014-03-14 | Systems and methods for active particle separation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2014/029336 A-371-Of-International WO2014144782A2 (en) | 2013-03-15 | 2014-03-14 | Systems and methods for active particle separation |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/013,793 Continuation US11383247B2 (en) | 2013-03-15 | 2018-06-20 | Systems and methods for active particle separation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20160296945A1 true US20160296945A1 (en) | 2016-10-13 |
Family
ID=51538374
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/777,505 Abandoned US20160296945A1 (en) | 2013-03-15 | 2014-03-14 | Systems and methods for active particle separation |
US16/013,793 Active 2034-06-18 US11383247B2 (en) | 2013-03-15 | 2018-06-20 | Systems and methods for active particle separation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/013,793 Active 2034-06-18 US11383247B2 (en) | 2013-03-15 | 2018-06-20 | Systems and methods for active particle separation |
Country Status (2)
Country | Link |
---|---|
US (2) | US20160296945A1 (en) |
WO (1) | WO2014144782A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021161221A1 (en) * | 2020-02-11 | 2021-08-19 | Khalifa University of Science and Technology | Systems and methods for enhancing the efficiency of separation processes |
US11204350B2 (en) | 2013-03-15 | 2021-12-21 | Ancera, Llc | Systems and methods for bead-based assays in ferrofluids |
US11285490B2 (en) * | 2015-06-26 | 2022-03-29 | Ancera, Llc | Background defocusing and clearing in ferrofluid-based capture assays |
US11383247B2 (en) | 2013-03-15 | 2022-07-12 | Ancera, Llc | Systems and methods for active particle separation |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10632463B2 (en) * | 2016-07-31 | 2020-04-28 | Ancera, Llc | Systems, devices and methods for cartridge securement |
EP4182476A2 (en) | 2020-07-14 | 2023-05-24 | Ancera, Inc. | Systems, devices and methods for analysis |
WO2022169905A1 (en) | 2021-02-02 | 2022-08-11 | Ancera Llc | Ferrofluid-based assay methods, and systems for parasite eggs or oocysts detection |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6038104A (en) * | 1996-10-31 | 2000-03-14 | Hitachi, Ltd. | Rotating disk type information storage apparatus having a movable member integrated with a support member |
US20040018611A1 (en) * | 2002-07-23 | 2004-01-29 | Ward Michael Dennis | Microfluidic devices for high gradient magnetic separation |
WO2010117458A1 (en) * | 2009-04-10 | 2010-10-14 | President And Fellows Of Harvard College | Manipulation of particles in channels |
US20110059468A1 (en) * | 2009-09-09 | 2011-03-10 | Earhart Christopher M | Magnetic separation device for cell sorting and analysis |
Family Cites Families (115)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3764540A (en) | 1971-05-28 | 1973-10-09 | Us Interior | Magnetofluids and their manufacture |
US3898156A (en) * | 1974-03-25 | 1975-08-05 | Avco Corp | Hyperbolic magnet poles for sink-float separators |
US4448534A (en) | 1978-03-30 | 1984-05-15 | American Hospital Corporation | Antibiotic susceptibility testing |
US5076950A (en) | 1985-12-20 | 1991-12-31 | Syntex (U.S.A.) Inc. | Magnetic composition for particle separation |
US4935147A (en) * | 1985-12-20 | 1990-06-19 | Syntex (U.S.A.) Inc. | Particle separation method |
US5135852A (en) | 1989-07-25 | 1992-08-04 | E. I. Du Pont De Nemours And Company | Piezoelectric cell growth biosensing method using polymer-metabolic product complex interactions |
GB2244135B (en) | 1990-05-04 | 1994-07-13 | Gen Electric Co Plc | Sensor devices |
US5439586A (en) | 1993-09-15 | 1995-08-08 | The Terry Fox Laboratory Of The British Columbia Cancer Agnecy | Magnetic filter with ordered wire array |
US6673533B1 (en) * | 1995-03-10 | 2004-01-06 | Meso Scale Technologies, Llc. | Multi-array multi-specific electrochemiluminescence testing |
DE69628016T2 (en) | 1995-06-16 | 2004-04-01 | University Of Washington, Seattle | MINIATURIZED DIFFERENTIAL EXTRACTION DEVICE AND METHOD |
EP0898496B1 (en) | 1996-05-17 | 2002-05-02 | Hubertus Exner | Device and process for separating particles with a rotary magnet system |
EP0925494B1 (en) | 1996-09-04 | 2001-12-19 | Scandinavian Micro Biodevices A/S | A micro flow system for particle separation and analysis |
FR2756501B1 (en) | 1996-11-29 | 1999-02-19 | Centre Nat Rech Scient | METHOD AND DEVICE FOR SEPARATING PARTICLES OR MOLECULES BY MIGRATION THROUGH A FERROFLUID |
US5998224A (en) | 1997-05-16 | 1999-12-07 | Abbott Laboratories | Magnetically assisted binding assays utilizing a magnetically responsive reagent |
DE19859461A1 (en) | 1998-12-22 | 2000-06-29 | Evotec Biosystems Ag | Method and device for the convective movement of liquids in microsystems |
US6623982B1 (en) | 1999-07-12 | 2003-09-23 | Immunivest Corporation | Increased separation efficiency via controlled aggregation of magnetic nanoparticles |
US6947953B2 (en) | 1999-11-05 | 2005-09-20 | The Board Of Trustees Of The Leland Stanford Junior University | Internet-linked system for directory protocol based data storage, retrieval and analysis |
AUPQ446699A0 (en) | 1999-12-06 | 2000-01-06 | Kocijan, Franz | Switchable (variable) permanent magnet device |
US6858184B2 (en) | 2000-03-16 | 2005-02-22 | Sri International | Microlaboratory devices and methods |
WO2001089696A2 (en) | 2000-05-24 | 2001-11-29 | Micronics, Inc. | Microfluidic concentration gradient loop |
JP2002049659A (en) | 2000-08-03 | 2002-02-15 | Disco Abrasive Syst Ltd | Experimental information exchange system |
US20020059132A1 (en) | 2000-08-18 | 2002-05-16 | Quay Steven C. | Online bidding for a contract to provide a good or service |
US7294503B2 (en) | 2000-09-15 | 2007-11-13 | California Institute Of Technology | Microfabricated crossflow devices and methods |
CN1325909C (en) | 2000-09-27 | 2007-07-11 | 清华大学 | Apparatus for particle operation and guide and use method thereof |
WO2003066191A1 (en) | 2002-02-04 | 2003-08-14 | Colorado School Of Mines | Laminar flow-based separations of colloidal and cellular particles |
JP2005521425A (en) | 2002-04-01 | 2005-07-21 | フルイディグム コーポレイション | Microfluidic particle analysis system |
US7753656B2 (en) | 2002-06-20 | 2010-07-13 | Lawrence Livermore National Security, Llc | Magnetohydrodynamic pump with a system for promoting flow of fluid in one direction |
US7810380B2 (en) | 2003-03-25 | 2010-10-12 | Tearlab Research, Inc. | Systems and methods for collecting tear film and measuring tear film osmolarity |
WO2005003326A2 (en) | 2003-03-28 | 2005-01-13 | Receptors Llc. | Artificial receptors including reversibly immobilized building blocks and methods |
CN100403109C (en) | 2002-10-01 | 2008-07-16 | 皇家飞利浦电子股份有限公司 | Multi-layered collimator |
US20040067167A1 (en) | 2002-10-08 | 2004-04-08 | Genoptix, Inc. | Methods and apparatus for optophoretic diagnosis of cells and particles |
US7220592B2 (en) | 2002-11-15 | 2007-05-22 | Eksigent Technologies, Llc | Particulate processing system |
EP1601874B1 (en) | 2003-03-10 | 2009-05-27 | The Regents Of The University Of Michigan | Integrated microfluidic control employing programmable tactile actuators |
US7341652B2 (en) | 2003-06-20 | 2008-03-11 | Groton Biosytems, Llc | Stationary capillary electrophoresis system |
US7460223B2 (en) | 2003-09-19 | 2008-12-02 | Applied Biosystems Inc. | Inverted orientation for a microplate |
US20050233472A1 (en) | 2003-09-19 | 2005-10-20 | Kao H P | Spotting high density plate using a banded format |
US20060024690A1 (en) | 2003-09-19 | 2006-02-02 | Kao H P | Normalization of data using controls |
US20060029948A1 (en) | 2003-09-19 | 2006-02-09 | Gary Lim | Sealing cover and dye compatibility selection |
US20060011305A1 (en) | 2003-09-19 | 2006-01-19 | Donald Sandell | Automated seal applicator |
US7417726B2 (en) | 2003-09-19 | 2008-08-26 | Applied Biosystems Inc. | Normalization of data using controls |
US20070015289A1 (en) | 2003-09-19 | 2007-01-18 | Kao H P | Dispenser array spotting |
US20060013984A1 (en) | 2003-09-19 | 2006-01-19 | Donald Sandell | Film preparation for seal applicator |
US20050237528A1 (en) | 2003-09-19 | 2005-10-27 | Oldham Mark F | Transparent heater for thermocycling |
US20070014694A1 (en) | 2003-09-19 | 2007-01-18 | Beard Nigel P | High density plate filler |
US20050280811A1 (en) | 2003-09-19 | 2005-12-22 | Donald Sandell | Grooved high density plate |
US7906345B2 (en) | 2003-11-12 | 2011-03-15 | The Board Of Trustees Of The Leland Stanford Junior University | Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules |
WO2005072855A1 (en) | 2004-01-28 | 2005-08-11 | Drexel University | Magnetic fluid manipulators and methods for their use |
CA2557819A1 (en) | 2004-03-03 | 2005-09-15 | The General Hospital Corporation | Magnetic device for isolation of cells and biomolecules in a microfluidic environment |
JP2006010529A (en) | 2004-06-25 | 2006-01-12 | Canon Inc | Separator and method for separating magnetic particle |
SG131130A1 (en) | 2004-07-06 | 2007-04-26 | Agency Science Tech & Res | Biochip for sorting and lysing biological samples |
US20090253215A1 (en) | 2004-12-23 | 2009-10-08 | Koninklijke Philips Electronics, N.V. | Method for controlling the flow of liquids containing biological material by inducing electro- or magneto-rheological effect |
DE102004062535A1 (en) * | 2004-12-24 | 2006-07-06 | Forschungszentrum Karlsruhe Gmbh | Semipermeable membrane system for magnetic particle fractions |
US20060188399A1 (en) | 2005-02-04 | 2006-08-24 | Jadi, Inc. | Analytical sensor system for field use |
US20070196820A1 (en) | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
EP1888790A2 (en) | 2005-05-06 | 2008-02-20 | The Regents of the University of California | Microfluidic system for identifying or sizing individual particles passing through a channel |
DK1910572T3 (en) | 2005-06-20 | 2016-03-14 | Advanced Cell Diagnostics Inc | Methods for Detecting Nucleic Acids in Single Cells and for Identifying Rare Cells from Large Heterogeneous Cell Populations |
WO2007044642A2 (en) | 2005-10-06 | 2007-04-19 | President And Fellows Of Harvard College And Children's Medical Center Corporation | Device and method for combined microfluidic-micromagnetic separation of material in continuous flow |
CA2637885A1 (en) | 2005-11-22 | 2007-05-31 | Mycrolab Pty. Ltd. | Microfluidic structures |
KR101157175B1 (en) | 2005-12-14 | 2012-07-03 | 삼성전자주식회사 | Microfluidic device and method for concentration and lysis of cells or viruses |
JP5268175B2 (en) | 2006-01-12 | 2013-08-21 | バイオセンス テクノロジーズ インク. | Method and composition for quickly performing a cell viability test |
US20090227044A1 (en) | 2006-01-26 | 2009-09-10 | Dosi Dosev | Microchannel Magneto-Immunoassay |
ES2393758T3 (en) | 2006-03-15 | 2012-12-27 | Micronics, Inc. | Integrated nucleic acid assays |
WO2007111938A2 (en) | 2006-03-23 | 2007-10-04 | The General Hospital Corporation | Inflammation-inhibitory serum factors and uses thereof |
US8741230B2 (en) | 2006-03-24 | 2014-06-03 | Theranos, Inc. | Systems and methods of sample processing and fluid control in a fluidic system |
US8637317B2 (en) | 2006-04-18 | 2014-01-28 | Advanced Liquid Logic, Inc. | Method of washing beads |
WO2008002563A2 (en) | 2006-06-26 | 2008-01-03 | Applera Corporation | Heated cover methods and technology |
WO2008002562A2 (en) | 2006-06-26 | 2008-01-03 | Applera Corporation | Compressible transparent sealing for open microplates |
JP2009544033A (en) | 2006-07-17 | 2009-12-10 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Attraction and separation of magnetic or magnetizable objects from the sensor surface |
WO2008147382A1 (en) | 2006-09-27 | 2008-12-04 | Micronics, Inc. | Integrated microfluidic assay devices and methods |
US7807454B2 (en) | 2006-10-18 | 2010-10-05 | The Regents Of The University Of California | Microfluidic magnetophoretic device and methods for using the same |
AU2007352361A1 (en) | 2006-11-14 | 2008-11-06 | The Cleveland Clinic Foundation | Magnetic cell separation |
CN201125246Y (en) | 2006-12-31 | 2008-10-01 | 刘文韬 | Cell separation apparatus |
US20090050569A1 (en) | 2007-01-29 | 2009-02-26 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Fluidic methods |
US8961898B2 (en) | 2007-03-30 | 2015-02-24 | Tokyo Institute Of Technology | Method for producing bilayer membrane and planar bilayer membrane |
US8292083B2 (en) | 2007-04-19 | 2012-10-23 | The Charles Stark Draper Laboratory, Inc. | Method and apparatus for separating particles, cells, molecules and particulates |
US20080302732A1 (en) | 2007-05-24 | 2008-12-11 | Hyongsok Soh | Integrated fluidics devices with magnetic sorting |
JP2010071693A (en) | 2008-09-16 | 2010-04-02 | Fujifilm Corp | Sensing method, sensing device, inspection chip, and inspection kit |
US20100075340A1 (en) | 2008-09-22 | 2010-03-25 | Mehdi Javanmard | Electrical Detection Of Biomarkers Using Bioactivated Microfluidic Channels |
JP2012504956A (en) | 2008-10-10 | 2012-03-01 | セントレ ナショナル デ ラ レシェルシェ サイエンティフィーク−ディーエーイー | Cell sorting device |
US8790916B2 (en) | 2009-05-14 | 2014-07-29 | Genestream, Inc. | Microfluidic method and system for isolating particles from biological fluid |
US8426214B2 (en) | 2009-06-12 | 2013-04-23 | University Of Washington | System and method for magnetically concentrating and detecting biomarkers |
EP2446271A1 (en) | 2009-06-26 | 2012-05-02 | Erasmus University Medical Center Rotterdam | Identifying circulating tumor cells (ctcs) using cd146 in breast cancers patients |
EP2473595A4 (en) | 2009-08-31 | 2013-04-24 | Mbio Diagnostics Inc | Integrated sample preparation and analyte detection |
GB2490051B (en) | 2009-12-07 | 2015-04-01 | Geco Technology Bv | Simultaneous joint inversion of surface wave and refraction data |
US8961878B2 (en) | 2009-12-07 | 2015-02-24 | Yale University | Label-free cellular manipulation and sorting via biocompatible ferrofluids |
DK2510335T3 (en) | 2009-12-07 | 2016-09-05 | Meso Scale Technologies Llc | Test Cassette |
US8614056B2 (en) | 2010-03-24 | 2013-12-24 | The Board Of Trustees Of The Leland Stanford Junior University | Microfluidic method for measurement or detection involving cells or biomolecules |
US20110262989A1 (en) | 2010-04-21 | 2011-10-27 | Nanomr, Inc. | Isolating a target analyte from a body fluid |
SG185113A1 (en) * | 2010-05-04 | 2012-12-28 | Agency Science Tech & Res | A microsieve for cells and particles filtration |
US20150041396A1 (en) | 2010-09-23 | 2015-02-12 | Battelle Memorial Institute | System and method of preconcentrating analytes in a microfluidic device |
WO2012057878A1 (en) * | 2010-10-28 | 2012-05-03 | Yale University | Microfluidic processing of target species in ferrofluids |
WO2012142664A1 (en) | 2011-04-20 | 2012-10-26 | Monash University | Method and device for trapping and analysing cells and the like |
US20140044600A1 (en) | 2011-08-12 | 2014-02-13 | Mcalister Technologies, Llc | Device for treating chemical compositions and methods for use thereof |
CN104159559B (en) | 2011-11-10 | 2018-01-02 | 拜奥法尔诊断有限责任公司 | Load phial |
CN104081210B (en) | 2011-12-23 | 2018-11-30 | 雅培医护站股份有限公司 | Optical detecting device with the actuating of pneumatic type sample |
WO2013155525A1 (en) | 2012-04-13 | 2013-10-17 | Biolumix, Inc | Ultra rapid blood culturing and susceptibility testing system |
US9278353B2 (en) | 2012-06-25 | 2016-03-08 | The General Hospital Corporation | Sorting particles using high gradient magnetic fields |
EP2711800B1 (en) | 2012-09-24 | 2019-11-20 | Telefonaktiebolaget LM Ericsson (publ) | I/O cell calibration |
US9594975B2 (en) | 2012-10-23 | 2017-03-14 | Hitachi, Ltd. | Image processing device and spinal canal evaluation method |
US20140214583A1 (en) | 2013-01-28 | 2014-07-31 | International Business Machines Corporation | Data distribution system, method and program product |
US20160299052A1 (en) | 2013-03-15 | 2016-10-13 | Ancera, Inc. | Methods and systems for time-of-flight affinity cytometry |
US20160299126A1 (en) | 2013-03-15 | 2016-10-13 | Ancera, Inc. | Methods and systems for drug discovery and susceptibility assay in using a ferrofluid |
US20160299132A1 (en) | 2013-03-15 | 2016-10-13 | Ancera, Inc. | Systems and methods for bead-based assays in ferrofluids |
US20160296945A1 (en) | 2013-03-15 | 2016-10-13 | Ancera, Inc. | Systems and methods for active particle separation |
WO2014144340A1 (en) | 2013-03-15 | 2014-09-18 | Ancera, Inc. | Systems and methods for three-dimensional extraction of target particles ferrofluids |
MX376578B (en) | 2013-03-15 | 2025-03-07 | Nanobiosym Inc | SYSTEMS AND METHODS FOR THE ANALYSIS OF NUCLEIC ACIDS AND PROTEINS WITH MOBILE DEVICES. |
WO2015041701A1 (en) | 2013-09-23 | 2015-03-26 | Hewlett-Packard Development Company, L.P. | Validate written data |
DE102014118846B4 (en) | 2014-12-17 | 2016-07-21 | Karlsruher Institut für Technologie | Device for measuring ultrafine particle masses |
US11285490B2 (en) | 2015-06-26 | 2022-03-29 | Ancera, Llc | Background defocusing and clearing in ferrofluid-based capture assays |
WO2017004595A1 (en) | 2015-07-01 | 2017-01-05 | Ancera, Inc. | Tunable affinity system and method for ferrofluid-based capture assays |
AU2016350734B2 (en) | 2015-11-02 | 2021-04-08 | Biofire Diagnostics, Llc | Sample preparation for difficult sample types |
EP3426403A4 (en) | 2016-03-08 | 2019-11-27 | Bio-rad Laboratories, Inc. | Microfluidic particle sorter |
US20170297028A1 (en) | 2016-04-15 | 2017-10-19 | Biofire Defense, Llc | Rapid Response Resistive Heater |
US10632463B2 (en) | 2016-07-31 | 2020-04-28 | Ancera, Llc | Systems, devices and methods for cartridge securement |
EP3723908A4 (en) | 2017-12-12 | 2021-07-14 | Ancera, LLC | Systems, methods and devices for magnetic scanning for ferrofluid based assay |
-
2014
- 2014-03-14 US US14/777,505 patent/US20160296945A1/en not_active Abandoned
- 2014-03-14 WO PCT/US2014/029336 patent/WO2014144782A2/en active Application Filing
-
2018
- 2018-06-20 US US16/013,793 patent/US11383247B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6038104A (en) * | 1996-10-31 | 2000-03-14 | Hitachi, Ltd. | Rotating disk type information storage apparatus having a movable member integrated with a support member |
US20040018611A1 (en) * | 2002-07-23 | 2004-01-29 | Ward Michael Dennis | Microfluidic devices for high gradient magnetic separation |
WO2010117458A1 (en) * | 2009-04-10 | 2010-10-14 | President And Fellows Of Harvard College | Manipulation of particles in channels |
US20110059468A1 (en) * | 2009-09-09 | 2011-03-10 | Earhart Christopher M | Magnetic separation device for cell sorting and analysis |
Non-Patent Citations (1)
Title |
---|
Kose, AR et al. Ferrofluid mediated nanocytometry. Lab on a Chip. 2012. 12: 190-196. Published on November 11, 2011. * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11204350B2 (en) | 2013-03-15 | 2021-12-21 | Ancera, Llc | Systems and methods for bead-based assays in ferrofluids |
US11383247B2 (en) | 2013-03-15 | 2022-07-12 | Ancera, Llc | Systems and methods for active particle separation |
US11285490B2 (en) * | 2015-06-26 | 2022-03-29 | Ancera, Llc | Background defocusing and clearing in ferrofluid-based capture assays |
US11833526B2 (en) | 2015-06-26 | 2023-12-05 | Ancera Inc. | Background defocusing and clearing in ferrofluid-based capture assays |
WO2021161221A1 (en) * | 2020-02-11 | 2021-08-19 | Khalifa University of Science and Technology | Systems and methods for enhancing the efficiency of separation processes |
US20230099118A1 (en) * | 2020-02-11 | 2023-03-30 | Khalifa University of Science and Technology | Systems and methods for enhancing the efficiency of separation processes |
Also Published As
Publication number | Publication date |
---|---|
US20190118190A1 (en) | 2019-04-25 |
US11383247B2 (en) | 2022-07-12 |
WO2014144782A3 (en) | 2014-12-18 |
WO2014144782A2 (en) | 2014-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11383247B2 (en) | Systems and methods for active particle separation | |
Guo et al. | Deformability based cell sorting using microfluidic ratchets enabling phenotypic separation of leukocytes directly from whole blood | |
Antfolk et al. | Continuous flow microfluidic separation and processing of rare cells and bioparticles found in blood–A review | |
AU2013286593B2 (en) | Methods and compositions for separating or enriching cells | |
JP5920895B2 (en) | Method and device for isolating cells from heterogeneous solutions using microfluidic capture vortices | |
Cima et al. | Label-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives | |
Tsutsui et al. | Cell separation by non-inertial force fields in microfluidic systems | |
Yousuff et al. | Microfluidic platform for cell isolation and manipulation based on cell properties | |
US9090663B2 (en) | Systems and methods for the capture and separation of microparticles | |
US20220107311A1 (en) | Systems and methods for bead-based assays in ferrofluids | |
Shi et al. | Magnetic particles assisted capture and release of rare circulating tumor cells using wavy-herringbone structured microfluidic devices | |
US20160237397A1 (en) | Methods and devices for breaking cell aggregation and separating or enriching cells | |
US11020745B2 (en) | Methods, systems and devices for concentration of particles | |
WO2018191534A1 (en) | Methods, compositions, and devices for separating and/or enriching cells | |
CN114929386A (en) | Asymmetric size-based nanopore membrane (ANM) filtration for efficient exosome separation, concentration and fractionation | |
Razak et al. | Efficient dielectrophoretic cell enrichment using a dielectrophoresis-well based system | |
EP2659984B1 (en) | Apparatus for self-extracting cells using magnetic force and method for self-extracting cells using the same | |
JP7191389B2 (en) | A Method for Filtration of Small-Volume Heterogeneous Suspensions in Digital Microfluidic Devices | |
US20230347345A1 (en) | Spiral inertial microfluidic devices and methods to remove contaminants | |
Chen et al. | Microfluidic Chips for Blood Cell Separation | |
Ohta et al. | Microdevices and Microsystems for Cell Manipulation | |
WO2023211901A1 (en) | Spiral inertial microfluidic devices and methods to remove contaminants | |
Pratt | Characterizing Cancer Cells Using Gedi Microdevices: Capture, In-Situ Analysis And Elution For Ex-Situ Analysis And Culture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ANCERA, INC., CONNECTICUT Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KOSER, HUR;REEL/FRAME:032532/0603 Effective date: 20140314 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: IAG HOLDINGS, LLC, SOUTH CAROLINA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ARECNA HOLDINGS, INC.;REEL/FRAME:047361/0236 Effective date: 20181017 Owner name: ANCERA, LLC, SOUTH CAROLINA Free format text: CHANGE OF NAME;ASSIGNOR:IAG HOLDINGS, LLC;REEL/FRAME:047364/0464 Effective date: 20181022 Owner name: ARECNA HOLDINGS, INC., DELAWARE Free format text: CHANGE OF NAME;ASSIGNOR:ANCERA, INC.;REEL/FRAME:047364/0412 Effective date: 20181017 |
|
AS | Assignment |
Owner name: ANCERA, INC., DELAWARE Free format text: CHANGE OF NAME;ASSIGNOR:ANCERA, LLC;REEL/FRAME:048789/0909 Effective date: 20130412 |
|
AS | Assignment |
Owner name: ANCERA INC., CONNECTICUT Free format text: CHANGE OF NAME;ASSIGNOR:ANCERA, LLC;REEL/FRAME:063016/0668 Effective date: 20211230 |